Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemopr
about
The dual role of iNOS in cancerNitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccinationPhospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effectNitric oxide and cisplatin resistance: NO easy answers.GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.Anti-proliferative effect of horehound leaf and wild cherry bark extracts on human colorectal cancer cells.NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenograftsInduction of oxidative stress as a mechanism of action of chemopreventive agents against cancerNO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue.Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition.Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action.The primary cilium influences interleukin-1β-induced NFκB signalling by regulating IKK activity.Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling.Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.Pharmacokinetic and pharmacodynamic study of NO-donating aspirin in F344 rats.
P2860
Q26786135-F8037FB0-A865-435A-BF55-9BB006DB442FQ33932627-4ACFB1BD-285F-42E2-9569-1BD6ED9E6AA7Q34253357-5A6D05D3-3E3B-4EFA-9A56-C54160DE80DBQ34574620-6D50FA18-20BF-4B4C-8DBC-2ED642B6D179Q34754579-F8880CFF-121B-47C2-847D-9BF8D17EB053Q35091403-22BB225D-EAE1-4AF6-80D7-B61409C97C2DQ36737451-28BD0178-FC1F-401E-8DA8-1E622478D716Q36857555-A9CB9068-B5F1-4FA3-B758-5952E837F019Q37078085-D1795F89-1613-47BB-B8F7-F8B1AC4B2D00Q37166556-860D1650-E500-48F2-8343-955AD6D0157DQ37182798-E2A5216B-CB63-4666-B42E-AFC64CC1D65BQ37185879-DBF210A9-CD84-4133-BEA3-B67C9AD2403EQ37222698-EC1A7B7B-9FB0-45D3-A525-4E887C92D3D5Q37269706-D0C86AD8-10F2-472E-B374-13F8507938D6Q37290658-108845E6-269A-4558-A4CF-1EF836FB431EQ37328516-715B80C5-D07D-442C-AD04-18856C1609D7Q38132159-0C3BD3B5-459E-4DC3-8B32-45C5AAB0A40FQ38336665-0F21B62B-1F4D-4985-9050-B43F07DECD68Q39004852-506AB453-A315-4792-8989-A7A913889118Q39361317-F9348A73-E0A2-4032-9671-2ACC2BDF755AQ39937602-D4E0B83B-0B71-45EC-B536-BE2550AAE3DFQ40059935-C2F64C7B-2B58-446D-A716-881A477FB9CDQ41858880-5387076B-F170-43C4-BB52-326F285E64E1Q41907929-DC0F2F6F-E320-403D-8EE4-980381C93CD1
P2860
Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemopr
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Growth inhibition of human col ...... tion: implications for chemopr
@en
Growth inhibition of human col ...... tion: implications for chemopr
@nl
type
label
Growth inhibition of human col ...... tion: implications for chemopr
@en
Growth inhibition of human col ...... tion: implications for chemopr
@nl
prefLabel
Growth inhibition of human col ...... tion: implications for chemopr
@en
Growth inhibition of human col ...... tion: implications for chemopr
@nl
P2093
P1433
P1476
Growth inhibition of human col ...... plications for chemoprevention
@en
P2093
Basil Rigas
Jennie L Williams
Jianjun Gao
Khosrow Kashfi
Levy Kopelovich
Niharika Nath
Thomas R Hundley
P304
P407
P577
2003-11-01T00:00:00Z